{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "42385-929",
      "generic_name": "Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate",
      "labeler_name": "Laurus Labs Limited",
      "brand_name": "Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate",
      "active_ingredients": [
        {
          "name": "EFAVIRENZ",
          "strength": "400 mg/1"
        },
        {
          "name": "LAMIVUDINE",
          "strength": "300 mg/1"
        },
        {
          "name": "TENOFOVIR DISOPROXIL FUMARATE",
          "strength": "300 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "42385-929-18",
          "description": "180 TABLET, FILM COATED in 1 BOTTLE (42385-929-18)",
          "marketing_start_date": "20200514",
          "sample": false
        },
        {
          "package_ndc": "42385-929-30",
          "description": "30 TABLET, FILM COATED in 1 BOTTLE (42385-929-30)",
          "marketing_start_date": "20200514",
          "sample": false
        },
        {
          "package_ndc": "42385-929-31",
          "description": "30 TABLET, FILM COATED in 1 BOTTLE (42385-929-31)",
          "marketing_start_date": "20200514",
          "sample": false
        },
        {
          "package_ndc": "42385-929-82",
          "description": "180 TABLET, FILM COATED in 1 BOTTLE (42385-929-82)",
          "marketing_start_date": "20200514",
          "sample": false
        },
        {
          "package_ndc": "42385-929-90",
          "description": "90 TABLET, FILM COATED in 1 BOTTLE (42385-929-90)",
          "marketing_start_date": "20200514",
          "sample": false
        },
        {
          "package_ndc": "42385-929-91",
          "description": "90 TABLET, FILM COATED in 1 BOTTLE (42385-929-91)",
          "marketing_start_date": "20200514",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Laurus Labs Limited"
        ],
        "rxcui": [
          "2001424"
        ],
        "spl_set_id": [
          "98342153-b9de-4318-aac4-9f8d19590cd7"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0342385929317"
        ],
        "nui": [
          "N0000175463",
          "N0000175460",
          "N0000009948",
          "N0000190118",
          "N0000187064",
          "N0000185504",
          "N0000182140",
          "N0000182141",
          "N0000175656",
          "N0000175462",
          "N0000009947"
        ],
        "pharm_class_epc": [
          "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
          "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
          "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]",
          "Cytochrome P450 3A Inducers [MoA]",
          "Cytochrome P450 2B6 Inducers [MoA]",
          "Cytochrome P450 2C9 Inhibitors [MoA]",
          "Cytochrome P450 2C19 Inhibitors [MoA]",
          "Cytochrome P450 3A4 Inhibitors [MoA]",
          "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
        ],
        "unii": [
          "JE6H2O27P8",
          "2T8Q726O95",
          "OTT9J7900I"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "80228c3a-152e-4170-9469-b4e13b137bcb",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20200514",
      "product_id": "42385-929_80228c3a-152e-4170-9469-b4e13b137bcb",
      "application_number": "ANDA213038",
      "brand_name_base": "Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate",
      "pharm_class": [
        "Cytochrome P450 2B6 Inducers [MoA]",
        "Cytochrome P450 2C19 Inhibitors [MoA]",
        "Cytochrome P450 2C9 Inhibitors [MoA]",
        "Cytochrome P450 3A Inducers [MoA]",
        "Cytochrome P450 3A4 Inhibitors [MoA]",
        "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
        "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
        "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
        "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
        "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
        "Non-Nucleoside Analog [EXT]",
        "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]",
        "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
        "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
        "Nucleosides [CS]"
      ]
    }
  ]
}